BD&L strategy for oncology leadership
Over the last decade, oncology revenue growth for top pharma players has largely been driven by BD&L. Our experts take a deep dive into the growing oncology market uncovering the top drivers and activities of revenue growth.
Explore the full analysis, takeaways, and strategic recommendations for how to engage in BD&L to drive growth in oncology.
Contact us.
To speak with our experts, fill out the form below.
Jump to a slide with the slide dots.
Clement Francois
Refining the Parallels Between EMA Expansion and JCA Implementation: Quantitative Insights and Recommendations
Parallels between EMA & JCA reveal risks of imbalance in EU HTA. Learn how to ensure fair, inclusive JCA implementation.
Read moreCharting your course: Navigate your launch journey with certainty
Expert strategies to navigate pre-launch challenges and ensure a successful life sciences product launch. Download the guide.
Read moreWill 2025 be a tipping point to unlock innovation in pharma commercialization?
Explore how AI is revolutionizing pharma, driving efficiency & impact. Get expert insights & trends for 2025. Download the report now!
Read more